Tamura et al.
NaI (330 mg, 2.2 mmol) in dry acetone (30 mL). After workup,
the crude material was chromatographed (5:1 n-hexane/AcOEt)
to give 7c (732 mg, quantitative) as a colorless oil: 1H NMR
(270 MHz, CDCl3) δ 1.49-1.58 (m, 2 H), 1.64-1.76 (m, 2 H),
2.00-2.04 (m, 2 H), 2.11 (br s, 2 H), 3.85 (s, 2 H), 4.60 (s, 2 H),
5.57 (br s, 1 H), 7.21-7.32 (m, 5 H); 1H NMR (270 MHz, C6D6)
δ 1.05-1.20 (m, 2 H), 1.20-1.35 (m, 2 H), 1.52-1.67 (m, 2 H),
1.75 (br s, 2 H), 3.56 (s, 2 H), 4.50 (s, 2 H), 5.20 (br s, 1 H),
7.00-7.31 (m, 5 H); 13C NMR (67.8 MHz, CDCl3) δ -2.3, 21.3,
22.7, 24.6, 27.6, 50.0, 127.3, 128.3, 128.6, 128.9, 137.4, 138.2,
167.3. Anal. Calcd for C15H18INO: C, 50.72; H, 5.11; N, 3.94.
Found: C, 50.65; H, 5.13; N 3.62.
imine was dissolved in toluene (20 mL). To this solution were
added successively pyridine (2.4 mL, 30 mmol) and a solution
of 2-bromopropanoyl bromide (4.75 g, 22 mmol) in toluene (50
mL) at 0 °C, and the mixture was stirred under the same
temperature for 1 h. The mixture was washed successively
with 5% hydrochloric acid, a saturated aqueous solution of
NaHCO3, and brine. After drying (MgSO4), the mixture was
concentrated under reduced pressure. The residue was purified
by column chromatography on silica gel (5:1 n-hexane/AcOEt)
to yield 2-bromo-N-(cyclohex-1-enyl)-N-methylpropionamide.
This material was used in the next step without further
purification. According to a procedure similar to that described
for the preparation of 1b, the bromo amide (550 mg, 1.9 mmol)
was treated with NaI (330 mg, 2.2 mmol) in dry acetone (30
mL). After workup, the crude material was chromatographed
(3:1 n-hexane/AcOEt) to give 15b (460 mg, 8%, two steps) as
a colorless oil: 1H NMR (270 MHz, CDCl3) δ 1.58-1.82 (m, 4
H), 1.93 (d, J ) 6.9 Hz, 3 H), 2.04-2.31 (m, 4 H), 2.98 (s, 3 H),
4.83 (q, J ) 6.9 Hz, 1 H), 5.81 (br s, 1 H); 13C NMR (67.8 MHz,
CDCl3) δ 14.4, 21.3, 22.6, 24.3, 24.5, 26.6, 34.7, 126.5, 139.8,
170.3. Anal. Calcd for C10H16INO: C, 40.97; H, 5.50; N, 4.78.
Found: C, 40.76; H, 5.65; N, 4.62.
Ben zyl-3-m eth yl-1,4,5,6,7,7a-h exah ydr oin dol-2-on e (16b)
a n d N-(Cycloh ex-1-en yl)-N-m et h ylp r op ion a m id e (17).
According to the general procedure, a boiling solution of 15b
(182 mg, 0.62 mmol) in toluene (20 mL) was treated with
Bu3SnH (198 mg, 0.68 mmol) and AIBN (10 mg, 0.062 mmol)
in toluene (45 mL) for 2 h. Workup and chromatography (from
20:1 to 1:5 n-hexane/AcOEt) gave 16b (20 mg, 24%) and 17
(53 mg, 63%). 16b: 1H NMR (270 MHz, CDCl3) δ 0.95 (qd, J
) 11.9, 3.3 Hz, 1 H), 1.26 (tt, J ) 13.2, 3.6 Hz, 1 H), 1.48 (qt,
J ) 13.2, 3.0 Hz, 1 H), 1.78 (t, J ) 1.5 Hz, 3 H), 1.82-2.12 (m,
3 H), 2.37-2.42 (m, 1 H), 2.69-2.79 (m, 1 H), 2.95 (s, 3 H),
3.50 (dd, J ) 11.2, 5.3 Hz, 1 H); HRMS calcd for C10H15NO
165.1154, found 165.1160. 17: 1H NMR (270 MHz, CDCl3) δ
1.11 (t, J ) 7.4 Hz, 3 H), 1.58-1.78 (m, 4 H), 2.08-2.14 (m, 4
H), 2.28 (q, J ) 7.4 Hz, 2 H), 2.98 (s, 3 H), 5.63 (br s, 1 H);
HRMS calcd for C10H17NO 167.1311, found 167.1313.
Meth yl N-Ben zylp yr oglu ta m a te (20) a n d Meth yl 2-(N-
Ben zyleth a n a m id o)p r op en oa te (21) (Ta ble 3, En tr y 5).
According to the general procedure, a boiling solution of 19b
(180 mg) and Bu3SnCl (813 mg, 2.5 mmol) in benzene was
treated with Bu3SnH (160 mg, 0.55 mmol) and AIBN (12 mg,
0.1 mmol) in benzene for 5 h. After workup, the crude material
was chromatographed (2:1 n-hexane/AcOEt) to give 203k (69
mg, 59%) and 213k (11 mg, 9%). 20: 1H NMR (270 MHz, CDCl3)
δ 2.02-2.63 (m, 4 H), 3.66 (s, 3 H), 4.01 (d, J ) 15.3 Hz, 1 H),
4.05 (dd, J ) 12.2, 8.9 Hz, 1 H), 5.00 (d, J ) 15.3 Hz, 1 H),
7.19-7.31 (m, 5 H). 21: 1H NMR (270 MHz, CDCl3) δ 2.00 (s,
3 H), 3.78 (s, 3 H), 4.68 (s, 2 H), 5.40 (s, 1 H), 6.32 (s, 1 H),
7.26 (m, 5 H). The 1H NMR spectral data of 20 and 21 were
identical with those reported.3k
N-(Cycloh ex-1-en yl)-N-[(2-iod o-4,5-m et h ylen ed ioxy)-
ben zyl]-2-iod oa ceta m id e (26). According to a procedure
similar to that described for the preparation of 7a , N-cyclohex-
1-enyl-N-[(2-iodo-4,5-methylenedioxy)benzyl]-2-chloroaceta-
mide (1.12 g, 52%) was obtained from cyclohexanone (490 mg,
5 mmol), 2-iodo-4,5-methylendioxybenzylamine26 (1.38 g, 5
mmol), triethylamine (4.1 mL, 30 mmol), and toluene (50 mL)
after chromatography on silica gel (10:1 n-hexane/AcOEt). 1H
NMR (270 MHz, CDCl3) δ 1.56-1.62 (m, 2 H), 1.70-1.75 (m,
2 H), 2.03-2.10 (m, 4 H), 4.13 (s, 2 H), 4.70 (s, 2 H), 5.48 (br
s, 1 H), 5.96 (s, 2 H), 6.98 (s, 1 H), 7.18 (s, 1 H). Anal. Calcd
for C16H17ClINO3: C, 44.31; H, 3.95; N, 3.23. Found: C, 44.16;
H, 3.97; N, 3.18. According to a treatment similar to that
described for the preparation of 7c, 26 (552 mg, 42%) was
obtained from the corresponding chloro amide (1.12 g, 2.5
mmol), NaI (2.0 g), and acetone (20 mL) after chromatography
on silica gel (10:1 n-hexane/AcOEt): 1H NMR (270 MHz,
CDCl3) δ 1.55-1.63 (m, 2 H), 1.70-1.79 (m, 2 H), 2.04-2.09
(s, 2 H), 2.19 (br s, 2 H), 3.84 (s, 2 H), 4.67 (s, 2 H), 5.60 (br s,
1 H), 5.96 (s, 2 H), 6.99 (s, 1 H), 7.18 (s, 1 H). Anal. Calcd for
Com p ou n d 2, 1-Ben zyl-1,3,3a ,4,5,6-h exa h yd r oin d ol-2-
on e (8), 1-Ben zyl-1,4,5,6,7,7a -h exa h yd r oin d ol-2-on e (9),
an d N-(Cycloh ex-1-en yl)-N-m eth ylacetam ide (10) (Tables
1 a n d 2): (a ) Ta ble 1, En tr y 1. According to the general
procedure, a solution of 7a (132 mg) in toluene was treated
with a solution of Bu3SnH and AIBN in toluene for 4.5 h.
Workup and chromatography (10:1 n-hexane/AcOEt) gave 2
(106 mg, 92%) as a colorless oil. The 1H NMR spectral data
were identical with those obtained from radical reaction of 1a .
(b) Ta ble 1, En tr y 2. According to a procedure similar to that
described above in a , R-bromo amide 7b (154 mg) was treated
with Bu3SnH to give 2 (63 mg, 55%), 8 (12 mg, 11%), and 94b
(13 mg, 11%). 8: 1H NMR (270 MHz, CDCl3) δ 1.25-1.65 (m,
2 H), 1.82-2.14 (m, 4 H), 2.20 (dd, J ) 15.4, 9.5 Hz, 1 H),
2.62-2.78 (m, 2 H), 4.47 (d of a pair of ABq, J ) 15.5 Hz, 1
H), 4.76 (d of a pair of ABq, J ) 15.5 Hz, 1 H), 4.77 (dd, J )
5.6, 3.3, 1 H), 7.21-7.36 (m, 5 H); HRMS calcd for C15H17NO
227.1312, found 227.1308. 9: 1H NMR (270 MHz, CDCl3) δ
0.92-1.11 (m, 1 H), 1.19-1.43 (m, 2 H), 1.17-2.39 (m, 4 H),
2.72 (br d, J ) 11.2 Hz, 1 H), 3.58 (dd, J ) 11.2, 5.9 Hz, 1 H),
4.17 (d, J ) 15.1 Hz, 1 H), 4.99 (d, J ) 15.1 Hz, 1 H), 5.80 (s,
1 H), 7.21-7.37 (m, 5 H). The 1H NMR spectral data were
identical with those reported. 4b (c) Ta ble 1, En tr y 3. Accord-
ing to a procedure similar to that described above in a , R-iodo
amide 7c (178 mg, 0.50 mmol) was treated with Bu3SnH to
give 8 (15 mg, 13%), 9 (12 mg, 11%), and 1030 (78 mg, 68%).
10: 1H NMR (270 MHz, CDCl3) δ 1.47-1.69 (m, 4 H), 1.97-
2.03 (m, 4 H), 2.06 (s, 3 H), 4.61 (s, 2 H), 5.39 (br s, 1 H), 7.22-
7.28 (m, 5 H); 13C NMR (67.8 MHz, CDCl3) δ 21.4, 21.5, 22.7,
24.6, 28.0, 49.4, 127.0, 128.0, 128.1, 128.6, 138.0, 138.8, 169.8;
HRMS calcd for C17H19NO 229.1467, found 229.1467. (d )
Ta ble 1, En tr y 4. According to the general procedure, a
boiling solution of 7a (132 mg) in toluene was treated with a
solution of (TMS)3SiH and AIBN in toluene for 8 h. After
evaporation, the residue was chromatographed (4:1 n-hexane/
AcOEt) to afford 2 (65 mg, 56%) and 9 (14 mg, 12%). (e) Ta ble
1, En tr y 5. According to a procedure similar to that described
above in d , a boiling solution of 7c (178 mg, 0.50 mmol) in
toluene was treated with a solution of (TMS)3SiH and AIBN
in toluene for 4 h. To the mixture was added a saturated
solution of NaHCO3, and the mixture was stirred vigorously
for 1 h. The mixture was extracted with AcOEt, dried (MgSO4),
and concentrated under reduced pressure. The residue was
chromatographed (3:1 n-hexane/AcOEt) to give 10 (87 mg,
76%). (f) Ta ble 2, En tr y 2. According to the general proce-
dure, a boiling solution of 7c (178 mg) and Bu3SnCl (813 mg,
2.5 mmol) in toluene was treated with a solution of Bu3SnH
and AIBN in toluene for 1 h. Workup and chromatography
gave 2 (21 mg, 18%), 8 (23 mg, 20%), 9 (32 mg, 28%), and 10
(10 mg, 9%). (g) Ta ble 2, En tr y 3. According to the general
procedure, a boiling solution of 7c (178 mg) and Bu3SnF (771
mg, 2.5 mmol) in toluene was treated with a mixture of
Bu3SnH and AIBN (12 mg, 0.1 mmol) in toluene for 2 h.
Workup and chromatography gave 2 (10 mg, 9%) and 8 (61
mg, 54%).
N -(Cycloh e x-1-e n yl)-N -m e t h yl-2-iod op r op ion a m id e
(15b). A mixture of cyclohexanone (2.1 mL, 20 mmol) and
methylamine (3 mL) in toluene (10 mL) was heated in a sealed
tube at 100 °C for 2 h. After cooling, the mixture was
concentrated under reduced pressure, and the residual crude
5544 J . Org. Chem., Vol. 67, No. 16, 2002